A series of novel 3-((2-((1 E, 4 E)-3-oxo-5-arylpenta-1, 4-dien-1-yl) phenoxy) methyl)-4 (3 H)- quinazolinone derivatives were designed and synthesized. Antiviral bioassays indicated that a few of the compounds exhibited higher antiviral activities against tobacco mosaic virus